Literature DB >> 20409468

Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor.

M Lochner1, S C R Lummis.   

Abstract

The 5-HT3 receptor is a member of the Cys-loop family of transmitter receptors. It can function as a homopentamer (5-HT3A-only subunits) or as a heteropentamer. The 5-HT3AB receptor is the best characterized heteropentamer. This receptor differs from a homopentamer in its kinetics, voltage dependence, and single-channel conductance, but its pharmacology is similar. To understand the contribution of the 5-HT3B subunit to the binding site, we created homology models of 5-HT3AB receptors and docked 5-HT and granisetron into AB, BA, and BB interfaces. To test whether ligands bind in any or all of these interfaces, we mutated amino acids that are important for agonist and antagonist binding in the 5-HT3A subunit to their corresponding residues in the 5-HT3B subunit and vice versa. Changes in [3H]granisetron binding affinity (Kd) and 5-HT EC50 were determined using receptors expressed in HEK-293 cells and Xenopus oocytes, respectively. For all A-to-B mutant receptors, except T181N, antagonist binding was altered or eliminated. Functional studies revealed that either the receptors were nonfunctional or the EC50 values were increased. In B-to-A mutant receptors there were no changes in Kd, although EC50 values and Hill slopes, except for N170T mutant receptors, were similar to those for 5-HT3A receptors. Thus, the experimental data do not support a contribution of the 5-HT3B subunit to the binding pocket, and we conclude that both 5-HT and granisetron bind to an AA binding site in the heteromeric 5-HT3AB receptor. Copyright 2010 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20409468      PMCID: PMC2856171          DOI: 10.1016/j.bpj.2009.12.4313

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  36 in total

1.  Evidence for expression of heteromeric serotonin 5-HT(3) receptors in rodents.

Authors:  M C Hanna; P A Davies; T G Hales; E F Kirkness
Journal:  J Neurochem       Date:  2000-07       Impact factor: 5.372

Review 2.  The molecular basis of the structure and function of the 5-HT3 receptor: a model ligand-gated ion channel (review).

Authors:  David C Reeves; Sarah C R Lummis
Journal:  Mol Membr Biol       Date:  2002 Jan-Mar       Impact factor: 2.857

3.  Prediction of 5-HT3 receptor agonist-binding residues using homology modeling.

Authors:  David C Reeves; Muhammed F R Sayed; Pak-Lee Chau; Kerry L Price; Sarah C R Lummis
Journal:  Biophys J       Date:  2003-04       Impact factor: 4.033

4.  Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor.

Authors:  G Hapfelmeier; C Tredt; R Haseneder; W Zieglgänsberger; B Eisensamer; R Rupprecht; G Rammes
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

5.  Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.

Authors:  K Brejc; W J van Dijk; R V Klaassen; M Schuurmans; J van Der Oost; A B Smit; T K Sixma
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

6.  A cytoplasmic region determines single-channel conductance in 5-HT3 receptors.

Authors:  Stephen P Kelley; James I Dunlop; Ewen F Kirkness; Jeremy J Lambert; John A Peters
Journal:  Nature       Date:  2003-07-17       Impact factor: 49.962

7.  Cation-pi interactions in ligand recognition by serotonergic (5-HT3A) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine.

Authors:  Darren L Beene; Gabriel S Brandt; Wenge Zhong; Niki M Zacharias; Henry A Lester; Dennis A Dougherty
Journal:  Biochemistry       Date:  2002-08-13       Impact factor: 3.162

8.  Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients.

Authors:  Pierre-Benoit Tremblay; Rolf Kaiser; Orhan Sezer; Nadja Rosler; Claudia Schelenz; Kurt Possinger; Ivar Roots; Jurgen Brockmoller
Journal:  J Clin Oncol       Date:  2003-06-01       Impact factor: 44.544

9.  Different binding orientations for the same agonist at homologous receptors: a lock and key or a simple wedge?

Authors:  Ting-Wei Mu; Henry A Lester; Dennis A Dougherty
Journal:  J Am Chem Soc       Date:  2003-06-11       Impact factor: 15.419

10.  Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E.

Authors:  Beate Niesler; Bernd Frank; Johannes Kapeller; Gudrun A Rappold
Journal:  Gene       Date:  2003-05-22       Impact factor: 3.688

View more
  25 in total

1.  VUF10166, a novel compound with differing activities at 5-HT₃A and 5-HT₃AB receptors.

Authors:  A J Thompson; M H P Verheij; I J P de Esch; S C R Lummis
Journal:  J Pharmacol Exp Ther       Date:  2012-02-03       Impact factor: 4.030

2.  Cysteine modification reveals which subunits form the ligand binding site in human heteromeric 5-HT3AB receptors.

Authors:  A J Thompson; K L Price; S C R Lummis
Journal:  J Physiol       Date:  2011-06-27       Impact factor: 5.182

3.  The 5-HT3B subunit affects high-potency inhibition of 5-HT3 receptors by morphine.

Authors:  Daniel T Baptista-Hon; Tarek Z Deeb; Nidaa A Othman; Douglas Sharp; Tim G Hales
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

4.  Binding sites for bilobalide, diltiazem, ginkgolide, and picrotoxinin at the 5-HT3 receptor.

Authors:  A J Thompson; R K Duke; S C R Lummis
Journal:  Mol Pharmacol       Date:  2011-04-19       Impact factor: 4.436

5.  Allosteric activation of the 5-HT3AB receptor by mCPBG.

Authors:  Timothy F Miles; Henry A Lester; Dennis A Dougherty
Journal:  Neuropharmacology       Date:  2014-12-23       Impact factor: 5.250

6.  Approaching the 5-HT₃ receptor heterogeneity by computational studies of the transmembrane and intracellular domains.

Authors:  Marta Del Cadia; Francesca De Rienzo; Maria Cristina Menziani
Journal:  J Comput Aided Mol Des       Date:  2013-06-16       Impact factor: 3.686

7.  Novel mechanism of modulation at a ligand-gated ion channel; action of 5-Cl-indole at the 5-HT3 A receptor.

Authors:  Andrew D Powell; Gillian Grafton; Alexander Roberts; Shannon Larkin; Nathanael O'Neill; Josephine Palandri; Reka Otvos; Alison J Cooper; Chris Ulens; Nicholas M Barnes
Journal:  Br J Pharmacol       Date:  2016-11-01       Impact factor: 8.739

8.  Association, interaction, and replication analysis of genes encoding serotonin transporter and 5-HT3 receptor subunits A and B in alcohol dependence.

Authors:  Chamindi Seneviratne; Jason Franklin; Katherine Beckett; Jennie Z Ma; Nassima Ait-Daoud; Thomas J Payne; Bankole A Johnson; Ming D Li
Journal:  Hum Genet       Date:  2013-06-12       Impact factor: 4.132

9.  Discovery of a novel allosteric modulator of 5-HT3 receptors: inhibition and potentiation of Cys-loop receptor signaling through a conserved transmembrane intersubunit site.

Authors:  Sarah M Trattnig; Kasper Harpsøe; Sarah B Thygesen; Louise M Rahr; Philip K Ahring; Thomas Balle; Anders A Jensen
Journal:  J Biol Chem       Date:  2012-05-15       Impact factor: 5.157

10.  The 5-HT3AB receptor shows an A3B2 stoichiometry at the plasma membrane.

Authors:  Timothy F Miles; Dennis A Dougherty; Henry A Lester
Journal:  Biophys J       Date:  2013-08-20       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.